Danaher Co. (DHR) Stake Lessened by Shell Asset Management Co.

Shell Asset Management Co. lowered its stake in shares of Danaher Co. (NYSE:DHR) by 4.4% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 120,925 shares of the conglomerate’s stock after selling 5,591 shares during the period. Shell Asset Management Co.’s holdings in Danaher were worth $13,140,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Fort L.P. acquired a new stake in Danaher during the 2nd quarter worth $119,000. Braun Bostich & Associates Inc. increased its stake in shares of Danaher by 506.4% during the second quarter. Braun Bostich & Associates Inc. now owns 1,225 shares of the conglomerate’s stock worth $121,000 after acquiring an additional 1,023 shares during the period. Reilly Financial Advisors LLC increased its stake in shares of Danaher by 62.6% during the third quarter. Reilly Financial Advisors LLC now owns 1,301 shares of the conglomerate’s stock worth $141,000 after acquiring an additional 501 shares during the period. Kaizen Advisory LLC boosted its holdings in Danaher by 150.3% during the second quarter. Kaizen Advisory LLC now owns 1,464 shares of the conglomerate’s stock worth $144,000 after buying an additional 879 shares in the last quarter. Finally, NEXT Financial Group Inc purchased a new stake in Danaher during the third quarter worth about $166,000. 77.31% of the stock is owned by hedge funds and other institutional investors.

In other news, insider William King sold 53,433 shares of the company’s stock in a transaction on Monday, November 5th. The shares were sold at an average price of $101.64, for a total value of $5,430,930.12. Following the completion of the transaction, the insider now directly owns 36,425 shares in the company, valued at $3,702,237. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Daniel L. Comas sold 36,000 shares of the company’s stock in a transaction on Thursday, November 8th. The shares were sold at an average price of $103.88, for a total transaction of $3,739,680.00. Following the completion of the transaction, the chief financial officer now owns 124,218 shares of the company’s stock, valued at $12,903,765.84. The disclosure for this sale can be found here. Insiders sold 150,007 shares of company stock valued at $15,202,163 in the last three months. Company insiders own 11.90% of the company’s stock.

Danaher stock opened at $102.41 on Monday. Danaher Co. has a 52-week low of $91.84 and a 52-week high of $110.13. The firm has a market capitalization of $71.78 billion, a PE ratio of 25.41, a price-to-earnings-growth ratio of 1.97 and a beta of 1.04. The company has a quick ratio of 1.08, a current ratio of 1.53 and a debt-to-equity ratio of 0.38.

Danaher (NYSE:DHR) last released its quarterly earnings data on Thursday, October 18th. The conglomerate reported $1.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.07 by $0.03. Danaher had a net margin of 14.07% and a return on equity of 11.59%. The company had revenue of $4.85 billion during the quarter, compared to analyst estimates of $4.80 billion. During the same quarter in the prior year, the business earned $1.00 earnings per share. The business’s quarterly revenue was up 7.2% compared to the same quarter last year. Research analysts anticipate that Danaher Co. will post 4.51 EPS for the current fiscal year.

Several analysts have issued reports on the stock. Robert W. Baird reduced their price target on shares of Danaher from $116.00 to $114.00 and set an “outperform” rating on the stock in a report on Friday, October 19th. Morgan Stanley upped their price target on shares of Danaher from $122.00 to $126.00 and gave the company an “overweight” rating in a report on Wednesday, October 10th. Finally, Zacks Investment Research raised shares of Danaher from a “hold” rating to a “buy” rating and set a $119.00 price target on the stock in a report on Wednesday, September 19th. One analyst has rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. Danaher presently has an average rating of “Buy” and an average target price of $112.14.

TRADEMARK VIOLATION WARNING: This piece was published by WKRB News and is the property of of WKRB News. If you are reading this piece on another website, it was stolen and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this piece can be viewed at https://www.wkrb13.com/2018/11/26/danaher-co-dhr-stake-lessened-by-shell-asset-management-co.html.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.

See Also: Inflation

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply